KHB: Obtained two medical device registration certificates

KEHUA Bio announced that the company and its controlling subsidiary, Suzhou Tianlong Biotechnology Co., Ltd., recently received two medical device registration certificates issued by the National Medical Products Administration, namely the company's Chlamydia trachomatis nucleic acid detection kit and Suzhou Tianlong's parainfluenza virus nucleic acid detection kit. Both registration certificates are valid from September 14, 2026 to September 13, 2031. The obtaining of the above registration certificates enriches the company's product line and will have a positive impact on the company's business development, but the impact on future operating revenue cannot be predicted for the time being.